Shamim Ruff - 10 Mar 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role: Director
Signature: /s/ Tracy Herson, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 10 Mar 2023
Net transactions value: -$282,568
Form type: 4
Filing time: 13 Mar 2023, 17:23:56 UTC
Previous filing: 09 Jun 2022
Next filing: 09 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Options Exercise	$5,437	+199	+3.8%	$27.32	5,422	10 Mar 2023	Direct
transaction	RETA	Class A common stock	Options Exercise	$46,092	+1,326	+24%	$34.76	6,748	10 Mar 2023	Direct
transaction	RETA	Class A common stock	Options Exercise	$146,513	+4,215	+62%	$34.76	10,963	10 Mar 2023	Direct
transaction	RETA	Class A common stock	Sale	$480,610	-5,740	-52%	$83.73	5,223	10 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Stock Option (right to buy)	Options Exercise	$0	-199	-100%	$0.000000^*	0	10 Mar 2023	Class A common stock	199	$27.32	Direct	F2
transaction	RETA	Stock Option (right-to-buy)	Options Exercise	$0	-1,326	-75%	$0.000000	443	10 Mar 2023	Class A common stock	1,326	$34.76	Direct	F3
transaction	RETA	Stock Option (right-to-buy)	Options Exercise	$0	-4,215	-75%	$0.000000	1,405	10 Mar 2023	Class A common stock	4,215	$34.76	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.67 to $83.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	The options vested in two equal installments on March 10, 2022 and June 10, 2022.
F3	The options vest in four equal installments on September 14, 2022, December 8, 2022, March 1, 2023, and June 7, 2023, subject to continued service through each vesting date.